COLLAGENEX PHARMACEUTICALS INC 4
4 · COLLAGENEX PHARMACEUTICALS INC · Filed Jun 27, 2007
Insider Transaction Report
Form 4
PFEIFFER DAVID F
Sr. VP, Sales and Marketing
Transactions
- Sale
Common Stock
2007-06-25$12.29/sh−2,265$27,837→ 19,235 total - Sale
Common Stock
2007-06-25$12.42/sh−60$745→ 11,500 total - Exercise/Conversion
Option to purchase common stock
2007-06-25−10,000→ 339,500 totalExercise: $10.63Exp: 2007-07-22→ Common Stock (10,000 underlying) - Sale
Common Stock
2007-06-25$12.34/sh−200$2,468→ 14,900 total - Exercise/Conversion
Common Stock
2007-06-25$10.63/sh+10,000$106,250→ 21,500 total - Sale
Common Stock
2007-06-25$12.30/sh−1,700$20,910→ 17,535 total - Sale
Common Stock
2007-06-25$12.31/sh−1,800$22,158→ 15,735 total - Sale
Common Stock
2007-06-25$12.36/sh−1,100$13,596→ 12,000 total - Sale
Common Stock
2007-06-25$12.41/sh−300$3,723→ 11,560 total - Sale
Common Stock
2007-06-25$12.38/sh−40$495→ 11,960 total - Sale
Common Stock
2007-06-25$12.32/sh−635$7,823→ 15,100 total - Sale
Common Stock
2007-06-25$12.39/sh−100$1,239→ 11,860 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2006.
- [F2]Represents partial exercise of an option to purchase an aggregate of 60,000 shares granted by the Issuer pursuant to its 1996 Stock Option Plan on July 23, 1997. Such option vested as follows: 12,000 shares subject to such option vested on July 23, 1998, 12,000 shares subject to such option vested on July 23, 1999, 12,000 shares subject to such option vested on July 23, 2000, 12,000 shares subject to such option vested on July 23, 2001 and 12,000 shares subject to such option vested on July 23, 2002.
- [F3]Includes multiple option grants with different prices and vesting dates.